NCT07537452

Brief Summary

The purpose of this study is to examine changes in cardiac autonomic nerve system function in patients receiving Hyperbaric oxygen therapy .

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
17

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Aug 2018

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2018

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

July 2, 2019

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2020

Completed
5.8 years until next milestone

First Posted

Study publicly available on registry

April 17, 2026

Completed
Last Updated

April 17, 2026

Status Verified

June 1, 2024

Enrollment Period

1.9 years

First QC Date

July 2, 2019

Last Update Submit

April 16, 2026

Conditions

Neurological Injury

Outcome Measures

Primary Outcomes (1)

  • Heart Rate Variability- Time messurment

    the square Root of the Mean Square successive RR differences(RMSSD) , Mean RR- Mean of R-R intervals.

    3 month

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients who are scheduled to receive a series of treatments at a pressure cell at Assaf Harofeh Hospital

You may qualify if:

  • Patients who are scheduled to receive a series of treatments at a pressure cell at Assaf Harofeh Hospital and are willing to participate in the study.

You may not qualify if:

  • A pulmonary disease that does not allow the patient to be admitted to a pressure cell (severe emphysema, moderate obstruction) .
  • patients that unable to sign informed consent form.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

hyperbaric center Asaf harofe medical center

Rishon LeZiyyon, Israel

Location

MeSH Terms

Conditions

Trauma, Nervous System

Condition Hierarchy (Ancestors)

Nervous System DiseasesWounds and Injuries

Study Officials

  • Shay Efrati, Prof

    Asaf-Harofhe MC

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 2, 2019

First Posted

April 17, 2026

Study Start

August 1, 2018

Primary Completion

July 1, 2020

Study Completion

July 1, 2020

Last Updated

April 17, 2026

Record last verified: 2024-06

Data Sharing

IPD Sharing
Will not share

Locations

IL(1)